Target intelligence / Profile preview

long intergenic non-protein coding RNA 29 (LINC00029)

Target: LINC00029
Molecular classification: Other (Long non-coding RNA, lncRNA)

Overview

long intergenic non-protein coding RNA 29 (LINC00029) is a member of the long non-coding RNA gene class found in humans. It does not code for a protein and is also referred to as bA305P22.4, C20orf51, and NCRNA00029. LINC00029 is classified as an "other" molecular entity due to its status as a non-coding RNA rather than a classical therapeutic target, and it does not have known biological functions, disease associations, or interacting drugs that are reported in standard reference databases[1][3][5][7][9].

Other names: bA305P22.4C20orf51NCRNA00029

Beyond the preview

Go deeper on long intergenic non-protein coding RNA 29 (LINC00029).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on long intergenic non-protein coding RNA 29 (LINC00029).

Explore the full profile